Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum92777Research ArticleKlyuchevye voprosy ranney terapii khronicheskoy obstruktivnoy bolezni legkikhLeshchenkoI. V-151020081010465028122021Copyright © 2008, Consilium Medicum2008[Lopez A.D, Shibuya K, Rao C et al. Chronic Obstructive Lung Disease: current burden and future projections. Eur Respir J 2006; 27 (1): 188–207.][Murray C.J, Lopez A.D. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349 (9064): 1498–504.][Глобальная инициатива по хронической обструктивной болезни легких. Под. ред. А.Г.Чучалина. М.: Атмосфера, 2007.][Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2007 (www.goldcopd.com).][Хроническая обструктивная болезнь легких. Федеральная программа. Практическое руководство для врачей. 2-е изд. Под ред. А.Г.Чучалина. М., 2004.][Salpeter S.R, Buckley N.S, Salpeter E.E. Meta - analysis: Anticholinergics, but not b - agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006; 21: 1011–9.][Milic-Emili J. Dynamic pulmonary hyperinflation and intrinsic PEEP: consequences and management in patients with chronic obstructive pulmonary disease. Rec Progress Med 1990; 81: 733–7.][O\'Donnell D.E, Fluge T, Gerken F et al. Effects of tiotropium on lung hyperinflation, dyspnоea and exercise tolerance in COPD. Eur Respir J 2004; 23: 86–94.][Tashkin D.P, Celli B, Decramer M et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31: 742–50.]